CD40 and neoplasm: Consistent with this hypothesis, tumor control was significantly improved in mice treated with RT+CTLA4i+anti-CD40 as compared to RT+CTLA4i, with the majority of mice showing tumor regression that was durable in some mice (Fig. 6b, c and Supplementary Fig. 17a).